To convince that Cav-1 is the molecular target of ursolic acid in impairing the glycolytic metabolism, the combination effect of Cav-1 siRNAs and ursolic acid on glycolytic metabolism of breast cancer cells was explored. The gene discussed is CAV1; the disease is breast carcinoma.